How Clinicians Decide Whether Combination Treatment Is Appropriate Clinicians determine whether combination treatment is appropriate through structured evaluation rather than default prescribing
No fear tactics either
No affiliation: PlexusDx is independent of LifeMD and holds no commercial relationship with any company discussed in this review
GLP-1 and the Gut Microbiome: A Bidirectional Story The relevance of probiotics during GLP-1 use is grounded in real biology that goes beyond just "gut health." A 2026 narrative review in the British Journal of Clinical Pharmacology examined the bidirectional relationship between GLP-1 RAs and the gut microbiome.[4] The review documents that: GLP-1 RAs themselves modify gut microbial composition, with several studies showing shifts in the Firmicutes/Bacteroidetes ratio and increased abundance of certain Bifidobacterium and Lactobacillus species during treatment The gut microbiome in turn produces metabolites (short-chain fatty acids, secondary bile acids) that stimulate endogenous GLP-1 secretion Microbiome composition may influence inter-individual response to GLP-1 therapy through inflammation, insulin sensitivity, and metabolic pathways The implication for probiotic supplementation: the period during GLP-1 use is one of meaningful microbial change driven by altered transit, reduced food intake, and direct drug effects
Adequate protein intake is essential for preserving muscle mass, supporting metabolic function, maintaining energy levels, and promoting long-term weight-loss successparticularly for women navigating hormonal transitions such as perimenopause, discussed further in Perimenopause Nutrition Foundations
